CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
158 hedge funds and large institutions have $337M invested in Clovis Oncology, Inc. in 2021 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 67 increasing their positions, 30 reducing their positions, and 28 closing their positions.
Holders
158
Holders Change
-5
Holders Change %
-3.07%
% of All Funds
2.76%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
24
Increased
67
Reduced
30
Closed
28
Calls
$21.8M
Puts
$26M
Net Calls
-$4.22M
Net Calls Change
+$10.3M
Top Buyers
1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$57.5M |
2 |
2
BlackRock
New York
|
$51.1M |
3 |
3
Morgan Stanley
New York
|
$9.18M |
4 |
IC
4
Ikarian Capital
Dallas,
Texas
|
$6.55M |
5 |
5
Principal Financial Group
Des Moines,
Iowa
|
$3.8M |